key: cord-0807854-ck69anys authors: Li, Fu; Liang, Zhichao; Cui, Shujuan; Lv, Bing; Feng, Zhaomin; Xu, Hui; Jia, Lei; Yang, Peng; Wang, Quanyi; Pan, Yang; Zhang, Daitao title: Importation of SARS-CoV-2 omicron variant in beijing, china date: 2022-04-19 journal: Biosaf Health DOI: 10.1016/j.bsheal.2022.04.003 sha: e862b405fbfb47e5393d411a427e7346a774c22c doc_id: 807854 cord_uid: ck69anys Omicron (B.1.1.529), the fifth Variant of Concern (VOC) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was firstly identified in November 2021 in South Africa. Omicron contains far more genome mutations than any other VOCs ever found, raising significant concerns about its increased transmissibility and immune evasion. Here, we report the importation of the Omicron variant into Beijing, China, in December 2021. Full-length genome sequences of five imported strains were obtained, with their genetic features characterized. The five imported strains contained 57 to 61 nucleotide substitutions, 39 deletions, and 9 insertions in the genome. A total of 30 to 32 amino acid changes were found in the spike proteins. The phylogenetic tree constructed by the maximum likelihood method showed that all five imported genomes belonged to Omicron (BA.1) (alias of B.1.1.529.1), which is leading to the current surge of COVID-19 cases worldwide. The globally increased COVID-19 cases driven by the Omicron variant pose a significant challenge to disease prevention and control in China. Continuous viral genetic surveillance and increased testing among international travellers are required to contain this highly contagious variant. The SARS-CoV-2 variant B.1.1.529 was initially detected in South Africa in a specimen collected on November 9, 2021, and was soon designated as the fifth Variant of Concern (VOC) by the World Health Organization (WHO) on November 26, 2021, and named Omicron [1, 2] . More than 30 amino acid mutations were detected in the spike protein of Omicron, including 15 amino acid mutations located in the receptor-binding domain (RBD), which raises significant concerns about the increase in pathogenicity transmissibility and immune escape of this variant [3] . Recently, the Omicron variant has replaced the Delta variant as the predominant strain in many countries and areas. As of February 22, 2022, the Omicron variant has been identified in almost all countries and is driving a new wave of COVID-19 cases worldwide[4]. Our study reported five overseas passengers or flight crew members arrived at Beijing Capital International Airport from December 17 to December 21, 2021. The first patient Finally, five SARS-CoV-2 full-length genomes were obtained. A phylogenetic tree was constructed by the maximum likelihood method using IQ-TREE software [5] . The result showed that all the five imported genomes belonged to the VOC/Omicron (Pango lineage (Fig. 1B) . Among these mutations, 15 to 16 mutations were located in the RBD of the spike proteins. Several private mutations were also found in these strains' spike, nucleocapsid, and nonstructural proteins. Imported Omicron variant strains have recently been identified and have caused outbreaks in several Chinese megacities [6, 7] , posing a significant challenge to dynamically zeroing case strategy. In addition, the first five imported Omicron variant infected cases in Beijing were detected in overseas travellers and flight crew members from four countries in a relatively short period of four days, suggesting that Omicron can quickly spread through international travel. Omicron contains numerous mutations in the spike, envelope, membrane, nucleocapsid, and nonstructural proteins that lead to increased viral transmissibility and immune evasion. A particular cluster of mutations (H655Y, N679K, and P681H) adjacent to the S1/S2 furin cleavage site could facilitate spike protein cleavage, which contributes to enhanced transmissibility [8] . Four amino acid mutations (A67V, T95I, Y145D, and L212I), six deletions (H69del, V70del, G142del, V143del, Y144del, and N211del), and one insertion (214insEPE) in the N-terminal domain (NTD) of spike protein are expected to reduce the sensitivity of Omicron to immune responses elicited by either natural infection or vaccination [9, 10] . It's worth noting that many mutations in the RBD region of Omicron may affect the binding of receptors and neutralizing antibodies. Five RBD mutations, including G339D, N440K, S477N, T478K, and N501Y, have been shown to enhance ACE2 receptor binding [11] . Seven RBD mutations, including K417N, G446S, E484A, Q493R, G496S, Q498R, and N501Y, were associated with the reduced binding affinity of RBD-targeted neutralizing antibodies [12] . We also found that two strains from patients 4 and 5 carried a private mutation, R346K, in the RBD region, which was found to be prevalent in the newly designated sub-lineage BA.1.1 of Omicron (Fig. 1B) . The R346K mutation has altered the interactions with monoclonal antibodies from class 2 [13] . Thus, further research should investigate if the R346K mutation in the RBD region leads to increased immune escape. Since the outbreak of the COVID-19 pandemic, SARS-CoV-2 has continuously evolved into a variety of Variant of Concern mutants, threatening global public health [14] . Phylogenetic analysis showed that Omicron was phylogenetically distinct from other SARS-CoV-2 VOCs and evolved into three main sub-lineages consisting of BA.1, BA.2 and BA.3. Furthermore, five imported strains in the study belonged to different subclades, showing Omicron's current genetic diversity. This emphasizes the significance of enhancing global SARS-CoV-2 genomic surveillance to provide evidence for the continuous evolution of circulating variants. In conclusion, a timely risk assessment should be conducted to adjust international travel-related control measures to slow the global spread of Omicron. And continuous genomic surveillance and rapid response are also required to contain this highly contagious variant. Continuous viral genomic surveillance and testing among international travellers are required to contain this highly contagious variant. Enhancing readiness for Omicron (B.1.1.529): technical brief and priority actions for member states WHO, Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern Heavily mutated omicron variant puts scientists on alert UFBoot2: Improving the Ultrafast Bootstrap Approximation The First Two Imported Cases of SARS-CoV-2 Omicron Variant-Tianjin Municipality, China An Imported Case and An Infected Close Contact of the Omicron Variant of SARS-CoV-2-Guangdong Province, China The Genotype to Phenotype Japan (G2P-Japan) Consortium, The CITIID-NIHR BioResource COVID-19 Collaboration SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization Considerable escape of SARS-CoV-2 Omicron antibody neutralization Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies R346K Mutation in the Mu Variant of SARS-CoV-2 Alters the Interactions with Monoclonal Antibodies from Class 2: A Free Energy Perturbation Study Classifications and research progress on prevalent SARS-CoV-2 variants We thank Beijing Customs District P.R.China for a sample and demographic information collection. This study was supported by the Capital's Funds for Health Improvement and The authors declare that there are no conflicts of interest.